(Q47786736)

5 February 2018

title

Parvovirus B19 transmission by a high-purity factor VIII concentrate. (English)

1 reference

5 February 2018

4

Dean Erdman

1 reference

5 February 2018

Bruce L. Evatt

8

object named as

Bruce Evatt

1 reference

5 February 2018

author name string

Chuan-ging Wu

1

1 reference

5 February 2018

Bobby Mason

2

1 reference

5 February 2018

Julia Jong

3

1 reference

5 February 2018

Laurel McKernan

5

1 reference

5 February 2018

Meredith Oakley

6

1 reference

5 February 2018

Mike Soucie

7

1 reference

5 February 2018

Mei-ying W Yu

9

1 reference

5 February 2018

publication date

1 June 2005

1 reference

5 February 2018

published in

Transfusion

1 reference

5 February 2018

volume

45

1 reference

5 February 2018

issue

6

1 reference

5 February 2018

page(s)

1003-1010

1 reference

5 February 2018

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

1 reference

Large-scale screening for human parvovirus B19 DNA by PCR: application to the quality control of plasma for fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

Human parvoviruses: implications for transfusion medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

Transient hypoplastic anemia caused by primary human parvovirus B19 infection in a previously untreated patient with hemophilia transfused with a plasma-derived, monoclonal antibody-purified factor VIII concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

Parvovirus B19 transmission by heat-treated clotting factor concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

Causality assessment of suspected virus transmission by human plasma products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

Establishment of the first World Health Organization International Standard for human parvovirus B19 DNA nucleic acid amplification techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

In vitro identification of a B19 parvovirus promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

Inactivation of parvovirus B19 during pasteurization of human serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

Heat sensitivity of human parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

Nanofiltration of plasma-derived biopharmaceutical products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

Genetic diversity within human erythroviruses: identification of three genotypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

The VP1-unique region of parvovirus B19: amino acid variability and antigenic stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

NAT screening of blood and plasma donations: evolution of technology and regulatory policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1537-2995.2005.04387.X

10.1111/J.1537-2995.2005.04387.X

21 January 2018

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

15935000

1 reference

5 February 2018